Roche (OTCMKTS:RHHBY) Downgraded by Hsbc Global Res to "Hold"

Roche (OTCMKTS:RHHBY - Get Free Report) was downgraded by research analysts at Hsbc Global Res from a "strong-buy" rating to a "hold" rating in a report released on Monday,Zacks.com reports.

A number of other analysts have also issued reports on the company. UBS Group upgraded Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. HSBC cut shares of Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Morgan Stanley initiated coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an "equal weight" rating on the stock. Finally, Sanford C. Bernstein upgraded shares of Roche to a "strong-buy" rating in a research report on Thursday, January 30th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Roche currently has a consensus rating of "Hold".

Roche Trading Up 3.8 %

Shares of OTCMKTS RHHBY traded up $1.50 during midday trading on Monday, reaching $41.08. The company's stock had a trading volume of 2,982,431 shares, compared to its average volume of 3,053,293. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. The firm has a 50 day moving average price of $40.68 and a 200-day moving average price of $38.63. Roche has a 12-month low of $29.72 and a 12-month high of $44.31.

Institutional Trading of Roche

Large investors have recently added to or reduced their stakes in the business. Moloney Securities Asset Management LLC lifted its position in shares of Roche by 53.8% in the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock valued at $1,672,000 after acquiring an additional 14,245 shares in the last quarter. Altrius Capital Management Inc lifted its holdings in Roche by 3.6% in the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after purchasing an additional 6,545 shares in the last quarter. Riverbridge Partners LLC boosted its stake in Roche by 6.7% in the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after purchasing an additional 2,381 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock valued at $5,716,000 after buying an additional 28,050 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Roche by 59.5% during the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock valued at $529,000 after buying an additional 4,794 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.